1. Coronavirus disease (COVID-19) . Geneva, Switzerland: World Health Organization; 2021. https://www.who.int/health-topics/coronavirus#tab=tab_1.
Google Scholar2. Coronavirus disease (COVID-19) . Rochester, MN: World Health Organization; 2021. https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963.
Google Scholar3. COVID data tracker . Atlanta, GA: Centers for Disease Control and Prevention; 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
Google Scholar4. WHO coronavirus (COVID-19) dashboard . Geneva, Switzerland: World Health Organization; 2021. https://covid19.who.int/.
Google Scholar5. Delta variant: what we know about the science . Atlanta, GA: Centers for Disease Control and Prevention; 2021. https://www.cdc.gov/coronavirus/2019-ncov/variants/delta-variant.html.
Google Scholar6. Van Doremalen, N, Bushmaker, T, Morris, DH, et al. Aerosol and surface stability of HCoV-19 (SAR-CoV-2) compared to SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi:10.1056/NEJMc2004973.
Google Scholar | Crossref | Medline7. Coronavirus (COVID-19) update: FDA issues authorization for first molecular non-prescription, at-home test . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-authorization-first-molecular-non-prescription-home-test.
Google Scholar8. Clinical pharmacology . Tampa, FL: Gold Standard Inc.; 2006. http://cp.gsm.com.
Google Scholar9. Coronavirus (COVID-19) update: FDA authorizes drug combination for treatment of COVID-19 . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19.
Google Scholar10. Coronavirus (COVID-19) update: FDA authorizes drug for treatment of COVID-19 . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19#:~:text=Today%2C%20the%20U.S.%20Food%20and,oxygen%2C%20non%2Dinvasive%20or%20invasive.
Google Scholar11. FDA authorizes REGEN-COV monoclonal antibody therapy for post-exposure prophylaxis (prevention) for COVID-19 . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-regen-cov-monoclonal-antibody-therapy-post-exposure-prophylaxis-prevention-covid-19.
Google Scholar12. Moderna COVID-19 vaccine . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine.
Google Scholar13. Janssen COVID-19 vaccine . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine.
Google Scholar14. FDA approves first COVID-19 vaccine . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.
Google Scholar15. Coronavirus (COVID-19) update: FDA authorizes additional vaccine dose for certain immunocompromised individuals . Silver Spring, MD: U.S. Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised.
Google Scholar16. Cominarty (COVID-19 vaccine, mRNA) . New York, NY: Pfizer Inc.; 2021.
Google Scholar17. BioNTech SE . A trial investigating the safety and effects of four BNT162 vaccines against COVID-2019 in healthy and immunocompromised adults. Accessed September 7, 2021. https://clinicaltrials.gov/ct2/show/study/NCT04380701.
Google Scholar18. BioNTech SE . Study to describe the safety, tolerability, immunogenicity, and efficacy of RNA vaccine candidates against COVID-19 in healthy individuals. Accessed September 7, 2021. https://clinicaltrials.gov/ct2/show/NCT04368728.
Google Scholar19. New CDC data: COVID-19 vaccination safe for pregnant people . CDC Online Newsroom. Centers for Disease Control and Prevention. Accessed October 9, 2021. https://www.cdc.gov/media/releases/2021/s0811-vaccine-safe-pregnant.html.
Google Scholar20. Breastfeeding and caring for newborns if you have COVID-19 . Division of Viral Diseases, National Center for Immunization and Respiratory Diseases (NCIRD). Accessed October 9, 2021. https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/pregnancy-breastfeeding.html.
Google Scholar21. Centers for Disease Control and Prevention . COVID-19 vaccinations in the United States. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total.
Google Scholar22. Kamar, N, Abravanel, F, Marion, O, et al. Three doses of an mRNA covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. doi:10.1056/NEJMc2108861.
Google Scholar | Crossref | Medline23. Learn more about COVID-19 vaccines from the FDA: learn about the evidence supporting FDA-approval of Comirnaty and FDA emergency use authorization of COVID-19 vaccines . https://www.fda.gov/consumers/consumer-updates/learn-more-about-covid-19-vaccines-fda.
Google Scholar24. Bernal, J, Andrews, N, Gower, C, et al. Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med. 2021;385(7):585–594. doi:10.1056/NEJMoa2108891.
Google Scholar | Crossref | Medline25. Krause, PR, Fleming, TR, Peto, R, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet. 2021;398:1377–1380. doi:10.1016/S0140-6736(21)02046-8.
Google Scholar | Crossref | Medline26. FDA authorizes booster dose of Pfizer-BioNTech COVID-19 vaccine for certain populations. Silver Spring, MD: U.S . Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations.
Google Scholar27. Shimabukuro, T, Kim, S, Myers, T, et al. Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384:2273–2282. doi:10.1056/NEJMoa2104983.
Google Scholar | Crossref | Medline28. Pfizer and BioNTech announce positive topline results from pivotal trial of covid-19 vaccine in children 5 to 11 years . New York, NY: Pfizer Inc.; 2021. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-positive-topline-results.
Google Scholar